Meiji Yasuda Asset Management Co Ltd.

Position in RPRX — Royalty Pharma plc

CIK 1491685 Tokyo, M0

Position in RPRX

as of Jun 30, 2026 · filed Aug 13, 2026 Compact

Position Value

$454,054

+$80,944 QoQ

Shares Held

8,098

+4.1% QoQ

Ownership

0.001%

of shares outstanding

% of Portfolio

0.02%

of 13F equity value

Holder Rank

#404

of 641 holders

Holding Since

Dec 2023

11 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

Meiji Yasuda Asset Management Co Ltd. holds $10,170,872 across 12 Biotechnology names. RPRX ranks #3 (4.5% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	12,740	$6,328,340
2	INCY	Incyte Corp	5,097	$577,795
3	RPRX	Royalty Pharma plc This page	8,098	$454,054
4	BMRN	Biomarin Pharmaceutical Inc	7,780	$445,171
5	ROIV	Roivant Sciences Ltd.	10,402	$368,126
6	JAZZ	Jazz Pharmaceuticals plc	1,452	$349,888
7	ALNY	Alnylam Pharmaceuticals, Inc.	1,085	$326,617
8	EXEL	Exelixis, Inc.	5,818	$316,557

11 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$454,054	8,098	+4.1%	Shares	Defined	2026-08-13
2026-03-31	$373,110	7,778	-3.5%	Shares	Defined	2026-05-14
2025-12-31	$311,361	8,058	+6.9%	Shares	Defined	2026-02-06
2025-09-30	$265,834	7,535	+1.1%	Shares	Defined	2025-11-13
2025-06-30	$268,603	7,455	-37.6%	Shares	Defined	2025-08-14
2025-03-31	$372,065	11,952	0.0%	Shares	Defined	2025-05-16
2024-12-31	$304,895	11,952	0.0%	Shares	Defined	2025-02-12
2024-09-30	$338,122	11,952	0.0%	Shares	Defined	2024-11-13
2024-06-30	$315,174	11,952	0.0%	Shares	Defined	2024-08-12
2024-03-31	$362,982	11,952	+10.0%	Shares	Defined	2024-05-15
2023-12-31	$305,113	10,862	—	Shares	Defined	2024-02-14
No filing history on record for this holder in this stock.